[Evaluation of the effect of betahistine in Meniere's disease by double-blind test and multivariate analysis].
D000328:Adult; D000368:Aged; D006631:Amine Oxidase (Copper-Containing) / Q000037:antagonists & inhibitors; D001621:Betahistine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D005021:Ethylamines / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008575:Meniere Disease / Q000188:drug therapy*; D008875:Middle Aged; D010919:Placebos; D011725:Pyridines / Q000627:therapeutic use*; D013223:Statistics as Topic
D005021:Ethylamines; D010919:Placebos; D011725:Pyridines; D006631:Amine Oxidase (Copper-Containing); D001621:Betahistine